HST vs STRO · P/E 16, rev $5.68B vs rev $62.0M
Host Hotels & Resorts Inc (HST) versus Sutro Biopharma (STRO) — a side-by-side from cached financials, not a winner call.
Host Hotels & Resorts Inc (HST) is a reit - hotel & motel company listed on US.
Sutro Biopharma (STRO) is a biotechnology company listed on NASDAQ.
Latest reported HST revenue for 2024-12-31 was $5.68B. Net income was $707.0M. Revenue was up 7.0% from 2023-12-31 to 2024-12-31. HST currently screens at market cap $15.94B and trailing P/E 15.6.
Latest reported STRO revenue for 2024-12-31 was $62.0M. Net income was -$227.5M. Revenue was down 59.6% from 2023-12-31 to 2024-12-31. STRO currently screens at market cap $470.8M.
HST currently screens at market cap $15.94B and trailing P/E 15.6. STRO currently screens at market cap $470.8M.
Not investment advice. Open the HST and STRO stock pages for the full models.
Not investment advice.